TREM2 sustains microglial expansion during aging and response to demyelination
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Microglia contribute to development, homeostasis, and immunity of the CNS. Like other tissue-resident macrophage populations, microglia express the surface receptor triggering receptor expressed on myeloid cells 2 (TREM2), which binds polyanions, such as dextran sulphate and bacterial LPS, and activates downstream signaling cascades through the adapter DAP12. Individuals homozygous for inactivating mutations in TREM2 exhibit demyelination of subcortical white matter and a lethal early onset dementia known as Nasu-Hakola disease. How TREM2 deficiency mediates demyelination and disease is unknown. Here, we addressed the basis for this genetic association using Trem2(-/-) mice. In WT mice, microglia expanded in the corpus callosum with age, whereas aged Trem2(-/-) mice had fewer microglia with an abnormal morphology. In the cuprizone model of oligodendrocyte degeneration and demyelination, Trem2(-/-) microglia failed to amplify transcripts indicative of activation, phagocytosis, and lipid catabolism in response to myelin damage. As a result, Trem2(-/-) mice exhibited impaired myelin debris clearance, axonal dystrophy, oligodendrocyte reduction, and persistent demyelination after prolonged cuprizone treatment. Moreover, myelin-associated lipids robustly triggered TREM2 signaling in vitro, suggesting that TREM2 may directly sense lipid components exposed during myelin damage. We conclude that TREM2 is required for promoting microglial expansion during aging and microglial response to insults of the white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the impaired ability of Trem2−/− or Apoe−/− microglia to remove damaged myelin hinders subsequent remyelination (Cantoni et al., 2015; Cantuti-Castelvetri et al., 2018; Poliani et al., 2015; Yeh et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 signals through its binding partner DAP12 (TYROBP) to elicit responses including phagocytosis, suppression of proinflammatory response, and promoting cell survival (Poliani et al., 2015; Takahashi et al., 2005).”
From Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer’s Disease Models (2018) · cites this paper as Poliani et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 ligands include a variety of molecules, such as bacterial wall products, Aβ oligomers, lipoproteins, and anionic lipids, such as phospholipids and sphingolipids29,32–35”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TREM2 is a phospholipid sensing receptor known to sustain microglial cell activation and expansion in response to demyelination or amyloid plaques in Alzheimer’s disease (AD) [8, 42, 50].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [42]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mice lacking TREM2, fewer microglia accumulate in the corpus callosum during demyelination due to reduced proliferation which in turn reduces myelin debris clearance [200–202].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [201]
Experimental — accuracy not yet measured
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417 · cited 1×
“As DAP12 is located in lipid rafts, engagement of TREM2 may induce aggregation and mobilization of multiple receptors to lipid rafts (47), thereby facilitating their clustering and activation of multiple signaling pathways.”
Evidence for the Formation of Symmetric and Asymmetric DLPC-DAPC Lipid Bilayer Domains
Ritter, M., Schmidt, S., Jakab, M., Paulmichl, M., & Henderson, R. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350122 · Cited by 3,923
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 2×
“As Trem2 –/– mice did not develop spontaneous demyelination, we wanted to determine been reported in CNS cells other than microglia (33, 34), recently published studies demonstrated that Trem2 is specifically expressed in microglia — but not other cells in the CNS — under steady-state conditions…”
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2, R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · cited 2×
“We recently demonstrated that human TREM2 detects a similarly broad range of anionic and zwitter-ionic lipid ligands (52).”
Self-citationFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 1×
“Very recent studies have shown that individuals heterozygous for a rare variant of TREM2 , R47H, have high risk for developing Alzheimer disease (AD) (34, 48, 49).”
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Cited by
Items 501–529 of 529
Spinal Cord Microglia Exhibit Impaired Repair Responses to Myelin DamagePreprint
Zupan, M. C., Petersen, J. M., Stover, A. C., Mohotti, N. D. S., & Hartley, M. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.23.707565
Introduction to microglial aging and its involvement in neurodegenerative diseases
Ben-Azu, B., Gargus, M., Verkhratsky, A., & Tremblay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00007-3 · Cited by 1
Catalano, M., & Limatola, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00004-8
Saiswaroop, R., Darshan, V. M. D., Naik, A. A., Bhagavatham, S. K. S., Kannan, V., Pradhan, S. S., Rathnakumar, S., Santhapuri, S. P., Naidu, P. B., Irfan, A. M., et al. (2026) · 3 Biotech · doi:10.1007/s13205-026-04715-0
The role of serotoninergic neurons in amyotrophic lateral sclerosis
Oussini, H. E. (2016) · theses.fr (ABES) · doi:10.70675/2431e8ddzd4e4z4710z81dcz14100daa6294
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Can low intensity rTMS reduce cognitive decline during normal and pathological aging ?
Fauquier, A. (2025) · theses.fr (ABES) · doi:10.70675/6b596768zac0dz4ecdzae59zdf708a0ac35d
Kong, Z., Shen, L., Ma, D., & Hou, J. (2026) · Clinical and Translational Discovery · doi:10.1002/ctd2.70140 · Cited by 1
Scarfone, V. M., Pachow, C., Nguyen, P. U., Lakatos, A., Torre, J.-J. D. L., Xie, A., Fernandez, K., Collado, C., Murray, K., Tinoco, R., et al. (2026) · Viruses · doi:10.3390/v18050550
“In the cuprizone model, TREM2-deficient microglia fail to upregulate phagocytic receptors, lipid catabolism genes, and trophic factors—including IGF-1 itself—resulting in impaired myelin debris clearance and persistent demyelination [59,60].”
Lietzke, E. E., Saeb, D., Aldrich, E. C., de Menezes, R. F., Bruce, K. D., & Sprenger, K. G. (2026) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2026.06.002 · Cited by 1
Clinical Indication of the Role of Inflammation in Alzheimer’s Disease
Kumar, A., Sarkar, N., Kundu, M., Singh, V., & Dasgupta, D. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010010
Wang, H., Wen, R., Parker, E., & Yang, L. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03083-9 · Cited by 4
“This activation allows TREM2 to sense lipid components released upon myelin damage [160], upregulate microglial activation markers (Iba1 and CD80) and phagolysosome activity markers (CD68 and LAMP1), promote OLs generation from OPCs, and improve the efficiency of myelin phagocytosis and degradation…”
Yang, G., Xu, X., & Xu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1893545 · Cited by 1
“In TREM2-null settings, this ef fl ux is inef fi cient, and microglia remain loaded with myelin-derived lipids, which translates into poor clearance of debris, fewer mature oligodendrocytes, axonal dystrophy, and persistent demyelination (83).”
InfluentialDecoding TREM2: A microglial receptor governing the fate of myelin
Zhang, Z., Zhang, W., Jin, L., Wei, C., Chen, H., 程相树, & Wei, J. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112815
Li, Y., Liu, S., & 蓝娇 (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1915244
“TREM2 drives aspects of microglial plaque engagement and DAM conversion (Poliani et al., 2015; Wang et al., 2022).”
Peng, Y., Jin, C. J., Sun, Y., Mu, W., & Zheng, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1898176
Li, C., Xu, Y., Tang, H., Cao, X., Sun, L., Shao, T., Xia, S., Bao, X., yizhun, Z., & Xu, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117388 · Cited by 1
Gene therapy in Alzheimer’s disease (AD)
Bemanalizadeh, M., Ashrafi, M., Eslami, M., Moein, S., Kazemi, A., & Mansouri, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00014-2
Gong, Q., Yu, X., Chen, S., Wan, K., Wang, Z., Tian, B., Zhu, X., Zhou, X., & Sun, Z. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1937413
“…relevance of serum sTREM2 emerged primarily in high-burden CSVD, whereas at lower burden other determinants of cognitive performance, such as cognitive reserve, lesion location, vascular risk factors, and systemic inflammation, may be more influential (Franceschi et al., 2018; Poliani et al., 2015).”
Dysfunction of lipid metabolism and lysosomal capacity: at the core of microglial aging?
Šimončičová, E., & Tremblay, M. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1884230
“…for microglial transformation into disease-associated microglia (DAM), a pro-phagocytic microglial response to damage-associated molecular patterns, protein aggregates and altered lipid homeostasis in aging and disease (Keren-Shaul et al., 2017; Krasemann et al., 2017; Poliani et al., 2015).”
Yao, J., Wei, Y., Zhang, F., Yuan, W., Li, Y., Sun, K., Wei, X., Huang, S., Zhong, J., Shang, J., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19101529
“…ester accumulation within microglia, indicating a defective capacity to degrade myelin lipid components and resulting in intracellular lipid overload [64]; after demyelinating injury, abundant myelin debris accumulates within lesions, and defective myelin degradation is observed under TEM [63].”
TDP-43 and ALS - what's wrong with my membranes?
Dahlhaus, R., Yalcin, I., Tischer, J., & Braun, R. J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107630 · Cited by 1
The microglial lineage: from molecular states to context-dependent functions
Li, C., Wu, Z., Xiang, X., & Li, H. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100378
“Early microgliosis is attenuated in TREM2-deficient mice, but microglia persist during recovery while myelin debris remains unresolved (Poliani et al., 2015).”
InfluentialLeon, J., Yoshinaga, S., Koya, I., Palafox, G., Ando, Y., Kubo, K., Moody, J., Takao, M., Carninci, P., Shin, J. W., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.07.757387
Jiao, H., Huang, H., Chen, S., Wang, P., Xiang, J., Xiang, G., & Zhao, L. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156715
Zhao, X., He, J., Yu, W., Lin, H., He, Q., Zhenyan, S., & Cheng, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06281-1
Glial lipid reprogramming in brain aging: Lipid identity, organelle stress, and redox vulnerability
Rana, M., Ko, W., Nepali, K., Ko, C.-Y., Yen, T., Jan, J., Taliyan, R., Li, C.-H., & Yang, C. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104453 · Cited by 1
Metadata
- Authors
- Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M.
- Affiliations
- University of Brescia (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Poliani, Pietro Luigi
- Wang, Yaming
- Colonna, Marco
- Venue
- Journal of Clinical Investigation
- Published
- 2015-04-20
- Volume
- 125
- Issue
- 5
- Pages
- 2161-2170
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4463196
- OpenAlex
- W2094831055
- Cited by
- 525
- References
- 58
- Citations by year
- 2026: 45 · 2025: 41 · 2024: 41 · 2023: 55 · 2022: 69 · 2021: 65 · 2020: 50 · 2019: 43 · 2018: 40 · 2017: 32 · 2016: 32 · 2015: 10
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, public-domain)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Eli Lilly and Company
- Cure Alzheimer's Fund
- Fondazione Cariplo
- National Institutes of Health (5p60dk020579-35, AG005681, DK020579)
- Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis
- Japan Society for the Promotion of Science (15K20969, 26893063)
- RIKEN
- National Institute on Aging (P50AG005681)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK‐020579, P60-DK-020579, P30DK020579)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- TREM2, microglia, aging, demyelination, cuprizone, myelin debris clearance, white matter, oligodendrocyte degeneration, myelin lipids, Nasu-Hakola disease, TREM2 knockout mice, microglial activation, phagocytosis, lipid degradation, axonal dystrophy
- MeSH terms
- Aging, Animals, Axons, Brain, Cell Count, Cuprizone, Demyelinating Diseases, Disease Models, Animal, Humans, Lipodystrophy, Membrane Glycoproteins, Myelin Sheath, Nerve Tissue Proteins, Osteochondrodysplasias, Phagocytosis, Receptors, Immunologic, Regeneration, Subacute Sclerosing Panencephalitis, Transcription, Genetic, Microglia, Genes, Reporter, Mice, Knockout, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.